Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A8192 Staurosporine6 CitationSummary: Protein kinase inhibitor,potent and cell permeable
-
C4363 Rp-8-bromo-Cyclic GMPS (sodium salt)Summary: cGMP-dependent protein kinase (cGK) inhibitor
-
C4394 Rp-8-pCPT-Cyclic GMPS (sodium salt)Summary: GMP-dependent protein kinases (cGKs) inhibitor
-
C4439 PKR InhibitorSummary: double-stranded RNA-activated protein kinase (PKR) inhibitor
-
C4953 HA-100 (hydrochloride)Summary: inhibitor of protein kinases (PKs)
-
B6619 RR-srcSummary: Tyrosine kinase substrate peptide
-
B6828 K 252aSummary: protein kinase inhibitor
-
B5001 H-9 dihydrochlorideSummary: Protein kinase inhibitor
-
B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: protein kinase inhibitor